Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy
Journal article published in 2016 by
Francesca Ricci,
Maddalena Fratelli 
,
Federica Guffanti ,
Luca Porcu,
Filippo Spriano,
Tiziana Dell’Anna,
Robert Fruscio,
Giovanna Damia
,
Federica Guffanti ,
Luca Porcu,
Filippo Spriano,
Tiziana Dell’Anna,
Robert Fruscio,
Giovanna Damia
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 